Industry Brief: Unpacking the drivers of dermatology dealmaking

Understand why M&A within dermatology has soared, and what have been the key factors underpinning its rise.

A few key points:

  • 2018 may well eclipse the prior high of deal value in dermatology in the US, soaring beyond $5.6 billion
  • PE buyers in particular have been boosting dermatology consolidation
  • Dermatology is well-suited as an investment opportunity, in part due to its multiple product lines and revenue sources

Click here to get the full brief.